Delivery Order SPE2DB22D2206-SPE2DB25FDP77
Award Date
10/4/24
Potential Completion Date
10/28/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company, to provide 120 capsules of the brand name cancer drug Tafinlar. The delivery order has a ceiling value of $16,278.68 and a period of performance through April 23, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price contract is for the supply of 4,568,120,296 units of the prescription medication Tafinlar 75 mg capsule. The contract has a period of performance through May 23, 2025. This award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tafinlar 75 mg capsules. The contract has a ceiling value of $8,139.33 and a performance period through July 29, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.82, is for the delivery of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with a period of performance through May 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
This federal contract award, valued at $17,792.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FGR57) with a firm fixed-price, non-set-aside contract type. It covers the delivery of 4,567,996,469 units of the prescription medication Tafinlar 75 mg capsule, with a performance period extending through May 13, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The delivery order has a ceiling value of $8,896.41 and is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,836.26 delivery order contract is for the supply of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm fixed price type with an ultimate completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...